Revance Therapeutics (RVNC) Institutional Ownership $3.65 0.00 (0.00%) As of 02/6/2025 Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Revance Therapeutics (NASDAQ:RVNC)CurrentInstitutional OwnershipPercentage97.70%Number ofInstitutional Buyers(last 12 months)82TotalInstitutional Inflows(last 12 months)$97.51MNumber ofInstitutional Sellers(last 12 months)30TotalInstitutional Outflows(last 12 months)$74.45M Get RVNC Insider Trade Alerts Want to know when executives and insiders are buying or selling Revance Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RVNC Institutional Buying and Selling by Quarter Revance Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/24/2025 Wellington Management Group LLP411,523$1.25M0.0%-7.7%0.394% 3/18/2025 CIBRA Capital Ltd1,139,979$3.47M2.4%N/A1.092% 2/18/2025 GTS Securities LLC22,590$69K0.0%-19.9%0.022% 2/18/2025 Alpine Global Management LLC12,202$37K0.0%N/A0.012% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC237,409$722K0.0%-10.5%0.227% 2/17/2025 Two Sigma Investments LP170,136$517K0.0%+8.6%0.163% 2/17/2025 Stonepine Capital Management LLC23,264$71K0.1%-97.2%0.022% 2/17/2025 ProShare Advisors LLC75,252$229K0.0%+19.3%0.072% 2/17/2025 Man Group plc443,544$1.35M0.0%+47.8%0.425% 2/17/2025 Newtyn Management LLC1,810,000$5.50M1.0%N/A1.734% Get the Latest News and Ratings for RVNC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Revance Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Millennium Management LLC1,551,372$4.72M0.0%+1,028.2%1.486% 2/17/2025 Fairfax Financial Holdings Ltd. Can21,158$64K0.0%N/A0.020% 2/17/2025 FORA Capital LLC60,868$185K0.0%+487.1%0.058% 2/17/2025 Deutsche Bank AG89,736$273K0.0%+43.1%0.086% 2/17/2025 Cubist Systematic Strategies LLC293,675$893K0.0%+27.3%0.281% 2/17/2025 Beryl Capital Management LLC5,935,009$18.04M4.1%N/A5.685% 2/17/2025 BNP Paribas Financial Markets13,662$42K0.0%-44.0%0.013% 2/17/2025 Ameriprise Financial Inc.23,706$72K0.0%+54.1%0.023% 2/17/2025 Algert Global LLC183,108$557K0.0%+44.5%0.175% 2/14/2025 Jane Street Group LLC113,150$344K0.0%-81.3%0.108% 2/14/2025 Schonfeld Strategic Advisors LLC13,400$41K0.0%-91.7%0.013% 2/14/2025 Northern Trust Corp991,043$3.01M0.0%+2.7%0.949% 2/14/2025 Vazirani Asset Management LLC350,000$1.06M3.3%+250.0%0.335% 2/14/2025 Susquehanna Fundamental Investments LLC551,224$1.68M0.0%N/A0.528% 2/14/2025 Two Sigma Securities LLC11,657$35K0.0%N/A0.011% 2/14/2025 Adage Capital Partners GP L.L.C.1,653,689$5.03M0.0%+57.5%1.584% 2/14/2025 Price T Rowe Associates Inc. MD103,915$316K0.0%+8.2%0.100% 2/14/2025 Alpine Global Management LLC12,202$37K0.0%N/A0.012% 2/14/2025 Hsbc Holdings PLC12,111$37K0.0%-99.0%0.012% 2/14/2025 MetLife Investment Management LLC60,514$184K0.0%+7.5%0.058% 2/14/2025 Natixis10,343$31K0.0%N/A0.010% 2/13/2025 Marshall Wace LLP252,468$768K0.0%-55.5%0.242% 2/13/2025 GABELLI & Co INVESTMENT ADVISERS INC.1,058,500$3.22M0.6%+26.0%1.014% 2/13/2025 Gamco Investors INC. ET AL58,418$178K0.0%+37.5%0.056% 2/13/2025 Gabelli Funds LLC1,262,487$3.84M0.0%+15.7%1.209% 2/13/2025 FIL Ltd4,196,095$12.76M0.0%+0.1%4.020% 2/13/2025 Invesco Ltd.63,537$193K0.0%+12.6%0.061% 2/13/2025 Wells Fargo & Company MN49,373$150K0.0%+27.6%0.047% 2/12/2025 RPO LLC17,969$55K0.1%N/A0.017% 2/12/2025 ExodusPoint Capital Management LP297,458$904K0.0%+138.0%0.285% Trump set to Boost Social Security Checks by 400%? (Ad)If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...Click here to see the details because the stakes couldn't be any higher.2/12/2025 Slotnik Capital LLC671,607$2.04M0.9%N/A0.643% 2/12/2025 Geode Capital Management LLC2,297,582$6.99M0.0%+0.3%2.201% 2/12/2025 Franklin Resources Inc.1,161,382$3.53M0.0%-75.7%1.113% 2/12/2025 Alliancebernstein L.P.3,497,112$10.63M0.0%+7.3%3.350% 2/12/2025 Wellington Management Group LLP411,523$1.25M0.0%-7.7%0.394% 2/12/2025 Norges Bank161,000$489K0.0%N/A0.154% 2/12/2025 JPMorgan Chase & Co.1,298,822$3.95M0.0%-64.3%1.244% 2/12/2025 Mint Tower Capital Management B.V.187,443$570K0.1%+212.4%0.180% 2/11/2025 Corebridge Financial Inc.51,761$157K0.0%-7.0%0.050% 2/11/2025 Vanguard Group Inc.5,625,091$17.10M0.0%-1.9%5.389% 2/11/2025 LPL Financial LLC13,375$41K0.0%-68.8%0.013% 2/11/2025 KLP Kapitalforvaltning AS24,400$74K0.0%N/A0.023% 2/11/2025 Magnetar Financial LLC2,556,345$7.77M0.2%+2.2%2.449% 2/10/2025 Commonwealth Equity Services LLC49,333$150K0.0%-36.8%0.047% 2/10/2025 Skandinaviska Enskilda Banken AB publ62,041$190K0.0%-57.7%0.059% 2/7/2025 Alpine Associates Management Inc.2,349,966$7.14M0.4%-43.5%2.251% 2/7/2025 Candriam S.C.A.299,039$909K0.0%N/A0.286% 2/6/2025 Charles Schwab Investment Management Inc.797,299$2.42M0.0%+0.8%0.764% 2/5/2025 New York Life Investment Management LLC295,670$899K0.0%+114.9%0.283% 2/4/2025 Los Angeles Capital Management LLC76,725$233K0.0%-14.6%0.073% 2/4/2025 Bank of New York Mellon Corp307,764$936K0.0%-5.7%0.295% 1/31/2025 Rice Hall James & Associates LLC678,541$2.06M0.1%-7.1%0.650% 1/30/2025 Rhumbline Advisers142,603$434K0.0%+5.1%0.137% 1/27/2025 Deltec Asset Management LLC100,000$304K0.1%N/A0.096% 1/17/2025 Inspire Investing LLC131,892$401K0.0%+69.0%0.126% 1/17/2025 SG Americas Securities LLC73,488$223K0.0%-4.5%0.070% 1/13/2025 FNY Investment Advisers LLC477,823$1.45M0.8%+160.4%0.458% 12/13/2024 Exome Asset Management LLC347,600$1.80M1.2%N/A0.333% 12/3/2024 Oddo BHF Asset Management Sas725,000$3.76M0.2%N/A0.695% 11/27/2024 Franklin Resources Inc.4,784,658$24.59M0.0%-23.6%4.583% 11/20/2024 Virtu Financial LLC23,129$120K0.0%N/A0.022% 11/16/2024 Geode Capital Management LLC2,289,654$11.89M0.0%-0.4%2.183% 11/15/2024 XTX Topco Ltd27,381$142K0.0%-60.8%0.026% 11/15/2024 Wellington Management Group LLP446,027$2.32M0.0%N/A0.425% 11/15/2024 State Street Corp2,433,963$12.63M0.0%+6.6%2.320% 11/15/2024 HighTower Advisors LLC147,400$765K0.0%-72.5%0.141% 11/14/2024 Walleye Capital LLC699,621$3.63M0.0%-83.7%0.667% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC265,210$1.38M0.0%+11.5%0.253% 11/14/2024 Stonepine Capital Management LLC820,000$4.26M2.7%-70.7%0.782% 11/14/2024 FORA Capital LLC10,367$54K0.0%N/A0.010% 11/13/2024 BNP Paribas Financial Markets24,390$127K0.0%-78.8%0.023% 11/13/2024 FMR LLC214,596$1.11M0.0%+28.6%0.205% 11/13/2024 Dynamic Technology Lab Private Ltd17,001$88K0.0%N/A0.016% 11/12/2024 Algert Global LLC126,730$658K0.0%+1,167.3%0.121% 11/12/2024 Charles Schwab Investment Management Inc.790,837$4.10M0.0%+5.5%0.754% 11/9/2024 Intech Investment Management LLC44,495$231K0.0%N/A0.042% 11/8/2024 Alpine Associates Management Inc.4,162,861$21.61M1.0%N/A3.971% 11/7/2024 LMR Partners LLP2,244,400$11.65M0.1%N/A2.141% 11/6/2024 Accredited Investors Inc.12,845$67K0.0%N/A0.012% 11/5/2024 GSA Capital Partners LLP20,819$108K0.0%N/A0.020% The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.This little-known company holds nearly 100 patents and trades for around $711/4/2024 Los Angeles Capital Management LLC89,825$466K0.0%-22.8%0.086% 10/28/2024 Rice Hall James & Associates LLC730,190$3.79M0.2%+2.5%0.697% 10/25/2024 China Universal Asset Management Co. Ltd.20,161$105K0.0%+64.3%0.019% 10/11/2024 Creative Planning10,858$56K0.0%N/A0.010% 10/10/2024 Inspire Investing LLC78,055$405K0.0%-43.9%0.074% 10/8/2024 Daymark Wealth Partners LLC15,000$78K0.0%-80.3%0.014% 10/3/2024 SG Americas Securities LLC76,963$399K0.0%N/A0.073% 8/21/2024 Stonepine Capital Management LLC2,800,000$7.20M6.6%+41.7%2.681% 8/16/2024 Algert Global LLC10,000$26K0.0%-92.7%0.010% 8/15/2024 The Manufacturers Life Insurance Company42,296$109K0.0%+29.4%0.040% (Data available from 1/1/2016 forward) RVNC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RVNC shares? During the previous two years, 171 institutional investors and hedge funds held shares of Revance Therapeutics. The most heavily invested institutionals were Thrivent Financial for Lutherans ($82.19M), Capital World Investors ($68.61M), Polar Capital Holdings Plc ($47.72M), Beryl Capital Management LLC ($18.04M), Vanguard Group Inc. ($17.10M), Rubric Capital Management LP ($12.85M), and FIL Ltd ($12.76M).Learn more on RVNC's institutional investors. What percentage of Revance Therapeutics stock is owned by institutional investors? 97.70% of Revance Therapeutics stock is owned by institutional investors. Learn more on RVNC's institutional investor holdings. Which institutional investors have been buying Revance Therapeutics stock? Of the 148 institutional investors that purchased Revance Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Beryl Capital Management LLC ($5.94M), Alpine Associates Management Inc. ($4.16M), Rubric Capital Management LP ($3.20M), LMR Partners LLP ($2.24M), Capital World Investors ($2.01M), Newtyn Management LLC ($1.81M), and Millennium Management LLC ($1.41M). How much institutional buying is happening at Revance Therapeutics? Institutional investors have bought a total of 42,182,642 shares in the last 24 months. This purchase volume represents approximately $293.02M in transactions. Which Revance Therapeutics major shareholders have been selling company stock? Of the 59 institutional investors that sold Revance Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Lazard Asset Management LLC ($11.97M), Franklin Resources Inc. ($5.10M), Walleye Capital LLC ($3.59M), JPMorgan Chase & Co. ($2.81M), Stonepine Capital Management LLC ($2.78M), Allspring Global Investments Holdings LLC ($1.94M), and Alpine Associates Management Inc. ($1.81M). How much institutional selling is happening at Revance Therapeutics? Institutional investors have sold a total of 38,030,881 shares in the last 24 months. This volume of shares sold represents approximately $317.88M in transactions. Related Companies JANX Institutional Ownership ETNB Institutional Ownership ADPT Institutional Ownership DYN Institutional Ownership SPRY Institutional Ownership EVO Institutional Ownership TVTX Institutional Ownership ANIP Institutional Ownership MESO Institutional Ownership OCUL Institutional Ownership This page (NASDAQ:RVNC) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revance Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revance Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
